Herbert A Reitsamer
Herbert A Reitsamer is an expert in Ophthalmology at Salzburger Landeskliniken (Austria). Herbert A Reitsamer has authored 195 publications, the most recent in 2026, and is an investigator in 2 clinical trials, 1 of them ongoing. SLR score: 534 (community average: 125). How the SLR is computed.
LeadR Profile
Ophthalmology
Subspecialties: Biochemistry - Neurology - Cardiology
Main Topics
Publications and Clinical Studies
Profile data updated on
Organizations
Career arc: 2002 - 2026
Number : 195
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Angiopoietin-2 and vascular endothelial growth factor α inhibition by faricimab reduces pericyte-to-myofibroblast transition and the myofibroblast phenotype in vitro. PMID 41881291 — actins, growth, pericytes, vascular endothelial growth factor a, myofibroblasts, ophthalmology, retina, fibrosis, phenotype, angiopoietins, therapeutics, fibronectins, retinal diseases, tissues, retinaldehyde, endothelial growth factors, angiopoietin-2 | Exp Eye Res | 2026 | 0 |
| Outcomes of the 63-μm Gelatin Microstent versus 45-μm Gelatin Microstent: An International Multi-Center Study. PMID 41638527 — eye, multiple chronic conditions, glaucoma, gelatin | Ophthalmol Glaucoma | 2026 | 0 |
| Cysteinyl leukotriene receptor 1 regulates cellular glucose levels in human retinal cells. PMID 41306485 — cells, receptors, leukotriene, cell survival, leukotrienes, therapeutics, retinaldehyde, diabetic retinopathy | Mol Vis | 2025 | 0 |
| The effect of CysLTR1 inhibition on cells of the retinal neurovascular unit in 5xFAD Alzheimer mice. PMID 41270820 — microglia, cells, pericytes, blood, ophthalmology, retina, brain, pathology, neuroglia, leukotrienes, therapeutics, retinaldehyde, blood circulation | Exp Eye Res | 2025 | 0 |
| Targeting pericytes in the retina: characterization of the inducible NG2-CreERT2 knock-in mouse model. PMID 40669220 — cells, pericytes, blood, capillaries, ophthalmology, retina, retinaldehyde | Exp Eye Res | 2025 | 0 |
Clinical Studies 2
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| XEN Glaucoma Gel Stent Versus Trabeculectomy NCT05439161 — stents, glaucoma, open-angle, glaucoma, visual acuity, trabeculectomy, exfoliation syndrome | N/A | Recruiting | 2023 |
LeadR Networks
Main global connection map